Author

Robert G. Maki

Hofstra UniversityORCID 0000-0002-9853-2528Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Bioinformatics· 1 Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 2 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Research Focus:gene regulatory network inference· 1 Organism:human· 1 Organism:mouse· 1

Frequent Co-Authors

Alessandro GardiniiD· 1 shared Alexandra IndegliaiD· 1 shared Atiya MansooriD· 1 shared Brian S. HernandeziD· 1 shared Cara Cipriano· 1 shared Carol J. BultiD· 1 shared Charles KelleriD· 1 shared Connor HilliD· 1 shared

Activity by Year

2019-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Alessandro GardiniORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

NAB2-STAT6 drives an EGR1-dependent neuroendocrine program in Solitary Fibrous Tumors

Connor Hill, Alexandra Indeglia, Francis J. Picone, Maureen E. Murphy, Cara Cipriano, Robert G. Maki, Alessandro Gardini

This study identifies NAB2-STAT6 as a driver of a neuroendocrine program in SFTs through its role in enhancing EGR1 target gene expression.

eLife · Aug 28, 2025Peer-reviewedCancer Biology

Probabilistic modeling of personalized drug combinations from integrated chemical screen and molecular data in sarcoma

Noah Berlow, Rishi Raj Rikhi, Mathew N. Geltzeiler, Jinu Abraham, Matthew N. Svalina, Lara Emily Davis, Erin Wise, Maria Mancini, Jonathan Christopher Noujaim, Atiya Mansoor, Michael J. Quist, Kevin L. Matlock, Martin W. Goros, Brian S. Hernandez, Yee C. Doung, , Charles Keller

This paper develops a probabilistic model integrating sequencing and functional assay data to predict personalized drug combinations for sarcoma patients with exhausted treatment options.

BMC Cancer · Jun 17, 2019Peer-reviewedBioinformatics